DB Commodity Double Short ETN DEE
55.00 USD 0.00 (+0.00%)
Jun 14, 2018, 9:34 AM EDT
55.00 Day range 55.00
55.00 52-week range 55.00
News
gurufocus.com Stoke Therapeutics Announces Completion of Successful Meeting with the FDA to Align on Planned U.S. NDA for Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicin
gurufocus.com Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16t [url="]Stoke Therapeutics, Inc.[/url] (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with
benzinga.com ETFs To Watch December 1, 2009 (OIH,